Odyssey Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | -9.7% | -31.1% | +36.6% | |
| – | -22.6% | -29.6% | +40.7% | |
| – | -78.2% | +12.5% | -29.5% | |
| – | – | – | – | |
| – | +5.2% | -1.5% | +7.4% | |
| – | -22.8% | -37.4% | -54.0% | |
| – | +18.9% | +5.6% | +30.7% | |
| – | -3.1% | +28.7% | -6.8% | |
| – | – | – | – | |
| – | -4.0% | -18.2% | +24.6% | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | +0.0% | +0.0% | -41.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.